Novogen Limited (ADR) (NASDAQ:NVGN)

CAPS Rating: 1 out of 5

The Company is a pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on the emerging field of phenolic technology.

Results 1 - 13 of 13

Recs

0
Member Avatar pchop12316 (37.84) Submitted: 1/24/2015 4:41:10 PM : Outperform Start Price: $2.33 NVGN Score: +8.15

ready to move back upstairs

Recs

2
Member Avatar zzlangerhans (99.85) Submitted: 1/24/2015 3:07:47 AM : Outperform Start Price: $2.31 NVGN Score: +9.15

I missed the last Novogen bump on CAPS because the stock was unratable but I caught it on the way down. Now I'm positioning myself for the next 250% leap. The only question is what the share price will be when that comes, and how long it will take.

I honestly think it would have been possible for a trader to make a living by focusing entirely on Novogen over the last five years. With a disciplined approach to tranche trading, one can accumulate a huge position at a decent cost basis and profit immensely through disciplined selling when that insane multibag day comes through. It's already happened three or four times since I've been following the stock, and I've never done remotely as well as I could have either because I accumulated too quickly or because I sold too impetuously. A decent trader could really squeeze this thing for millions.

Last time I thought 4 was the bottom and accumulated a full 10000 shares with a cost basis of 3.8. The share price proceeded to drop well below 2 before it eventually tripled to over 5. I only made about 5000 for my efforts. This time round I'll start accumulating gradually below 2.3, then refuse to add for at least a month. If the stock is declining I won't touch it until it clearly plateaus. I plan to eventually own 20000 shares, hopefully with a cost basis below 2 if not even lower. When that pre-market craziness starts, I'm going to suck the marrow out of the spike and then short the pig all the way down.

And the science? Give me a break. Novogen is just bloodsport.

Recs

0
Member Avatar seymourfroggs (43.65) Submitted: 1/17/2015 1:53:16 AM : Outperform Start Price: $2.30 NVGN Score: +8.41

Small lean group, all scientists, but with clear idea about not letting go of their property; hanging on to 51% come H or HW.
Two paths, but focusing on one of these. A molecule which is both a rather fundamental and quite selective "poison". It is the only thing I know of that will kill cancer stem cells, so making cancer recurrence less likely. It works on several cancer types.
Its soon to start being trialed in a safety study.
I like the expertise, the cautious enthusiasm, and what look like two superb molecules.

Recs

0
Member Avatar TMFFlygal (99.06) Submitted: 1/16/2015 8:12:55 PM : Underperform Start Price: $2.30 NVGN Score: -8.41

Junk

Recs

0
Member Avatar Haugurafpeningum (29.53) Submitted: 1/31/2014 9:36:01 AM : Outperform Start Price: $4.13 NVGN Score: -53.06

z z

Recs

1
Member Avatar palmeiras (< 20) Submitted: 11/5/2013 12:52:50 AM : Outperform Start Price: $6.18 NVGN Score: -73.43

CS-6 drug shows high potency. Potential partnership announced in letter to shareholders CEO trialed an earlier version of the drug and sent his cancer into remission (that's faith in your product!)

Recs

1
Member Avatar deuspecuniae (95.95) Submitted: 5/1/2008 12:11:16 PM : Outperform Start Price: $190.15 NVGN Score: -146.87

The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical stocks have been beaten down this past winter, and I see a reversal across the entire sector. Also, those companies already on a run will continue due to the upward momentum this summer from key reversals and upgrades throughout the sector.

Recs

0
Member Avatar skytalon1 (< 20) Submitted: 4/22/2008 8:51:37 PM : Outperform Start Price: $207.00 NVGN Score: -148.97

i HAVE NOT DONNE ANY HOMEWORK ON THIS ONE BUT HAVE A GOOD FEELING IT WILL GET HOT IN TIME

Recs

0
Member Avatar Biotech2008 (69.61) Submitted: 1/4/2008 9:58:21 PM : Outperform Start Price: $134.15 NVGN Score: -144.74

applefoot @5.53

Recs

0
Member Avatar tharlow (88.70) Submitted: 11/9/2007 12:04:31 AM : Outperform Start Price: $190.00 NVGN Score: -142.14

Ready to explode.

Recs

0
Member Avatar COOLJOB (< 20) Submitted: 9/23/2007 7:44:43 PM : Outperform Start Price: $200.00 NVGN Score: -135.87

Wish to keep it to myself

Recs

0
Member Avatar Kywong (< 20) Submitted: 6/14/2007 2:35:48 AM : Outperform Start Price: $217.50 NVGN Score: -137.54

The base technology upon which Novogen is basing its work shows plenty of promise as an enabler. I suspect that being a 'toolmaker' for drug developers is a safer proposition than being an out and out drug developer.

Recs

0
Member Avatar LALetal (< 20) Submitted: 2/28/2007 1:09:57 PM : Outperform Start Price: $272.25 NVGN Score: -148.94

Flying under the radar with potenial

Results 1 - 13 of 13

Featured Broker Partners


Advertisement